News
Moderna shares hit a low
Digest more
Speaking at a WIRED event Tuesday, Moderna CEO Stéphane Bancel said he was “encouraged” by the company’s dialogue with the ...
25mon MSN
States Are Taking Steps to Make COVID-19 Vaccines Accessible Amid New FDA Limits: What to Know
The “newly approved sources of authority” include the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Pediatrics (AAP), the American Academy of Family Physicians ...
The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...
Moderna is working with advanced technology to help transform the way medicines are created, but is that enough reason to ...
This drop brings the stock's year-to-date decline to almost 45%. A key question now is how MRNA's performance compares to ...
The Food and Drug Administration rescinded the emergency use authorization that made COVID-19 shots available for healthy ...
Pfizer and Moderna on Wednesday defended their COVID-19 vaccines as having saved millions of lives worldwide, in separate ...
Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its investigational mRNA therapeutics have been accepted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback